Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
about
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis.Effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients with moderate to severe chronic kidney disease: Meta-analysis of randomized controlled trials using unadjusted data.An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.Sitagliptin: A Review in Type 2 Diabetes.Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients.The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction.Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease.The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.
P2860
Q30249371-56DD5DBB-1FE9-426D-8638-C493DA9F8363Q30846870-708C1AA6-437F-4E19-8AF6-F1D712201435Q31171482-8C04F0D6-46E6-47AC-A5C0-F0C742F440A4Q37141607-3175BEEA-EA33-41DA-8D8C-AF0B01CC612DQ38644587-C7C84F83-A471-4F63-9F13-1B75A3BA786EQ38682317-49BCA8CA-2409-4073-8918-37E737BE8A38Q39081543-16400854-A64A-496D-82D9-5258E9B0234EQ40651201-795E3771-575C-48AF-8CE6-7527093E761CQ46304493-E05EF921-6ECE-4AEF-9B23-FD20FF2F695BQ47566180-8546E7BB-D3D4-4ED8-8B33-8D95FD3EA49CQ49592715-68B1CE94-37F3-405F-BB05-C23BE5B9718B
P2860
Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of vildagliptin and ...... : a randomised clinical trial.
@ast
Comparison of vildagliptin and ...... : a randomised clinical trial.
@en
type
label
Comparison of vildagliptin and ...... : a randomised clinical trial.
@ast
Comparison of vildagliptin and ...... : a randomised clinical trial.
@en
prefLabel
Comparison of vildagliptin and ...... : a randomised clinical trial.
@ast
Comparison of vildagliptin and ...... : a randomised clinical trial.
@en
P2093
P2860
P1433
P1476
Comparison of vildagliptin and ...... : a randomised clinical trial.
@en
P2093
Anja Schweizer
James E Foley
Marc S Rendell
Valentina Lukashevich
Wolfgang Kothny
P2860
P2888
P304
P356
10.1007/S00125-015-3655-Z
P577
2015-06-12T00:00:00Z